BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30632669)

  • 1. UNC5D, suppressed by promoter hypermethylation, inhibits cell metastasis by activating death-associated protein kinase 1 in prostate cancer.
    Dong D; Zhang L; Bai C; Ma N; Ji W; Jia L; Zhang A; Zhang P; Ren L; Zhou Y
    Cancer Sci; 2019 Apr; 110(4):1244-1255. PubMed ID: 30632669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor-suppressive function of UNC5D and its repressed expression in renal cell carcinoma.
    Lu D; Dong D; Zhou Y; Lu M; Pang XW; Li Y; Tian XJ; Zhang Y; Zhang J
    Clin Cancer Res; 2013 Jun; 19(11):2883-92. PubMed ID: 23589179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpain-2 triggers prostate cancer metastasis via enhancing CRMP4 promoter methylation through NF-κB/DNMT1 signaling pathway.
    Gao X; Mao YH; Xiao C; Li K; Liu W; Li LY; Pang J
    Prostate; 2018 Jun; 78(9):682-690. PubMed ID: 29601651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTSS1 hypermethylation is associated with prostate cancer progression.
    Chen J; Huang L; Zhu Q; Wang Z; Tang Z
    J Cell Physiol; 2020 Mar; 235(3):2687-2697. PubMed ID: 31541465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis.
    Pan J; Chen Y; Mo C; Wang D; Chen J; Mao X; Guo S; Zhuang J; Qiu S
    PLoS One; 2014; 9(3):e92815. PubMed ID: 24664224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling.
    Li Q; Ye L; Zhang X; Wang M; Lin C; Huang S; Guo W; Lai Y; Du H; Li J; Song L; Peng X
    Cancer Lett; 2017 Aug; 402():166-176. PubMed ID: 28602974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.
    Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
    Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
    Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression.
    Esposito S; Russo MV; Airoldi I; Tupone MG; Sorrentino C; Barbarito G; Di Meo S; Di Carlo E
    Oncotarget; 2015 Jul; 6(19):17121-34. PubMed ID: 25686823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional Repressor DAXX Promotes Prostate Cancer Tumorigenicity via Suppression of Autophagy.
    Puto LA; Brognard J; Hunter T
    J Biol Chem; 2015 Jun; 290(25):15406-15420. PubMed ID: 25903140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
    Ramalho-Carvalho J; Martins JB; Cekaite L; Sveen A; Torres-Ferreira J; Graça I; Costa-Pinheiro P; Eilertsen IA; Antunes L; Oliveira J; Lothe RA; Henrique R; Jerónimo C
    Cancer Lett; 2017 Jan; 385():150-159. PubMed ID: 27984115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma.
    Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation.
    Ummanni R; Jost E; Braig M; Lohmann F; Mundt F; Barett C; Schlomm T; Sauter G; Senff T; Bokemeyer C; Sültmann H; Meyer-Schwesinger C; Brümmendorf TH; Balabanov S
    Mol Cancer; 2011 Oct; 10():129. PubMed ID: 21999842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
    Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
    J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
    Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
    Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
    J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation and aberrant expression of Sprouty1 in human prostate cancer.
    Kwabi-Addo B; Ren C; Ittmann M
    Epigenetics; 2009 Jan; 4(1):54-61. PubMed ID: 19164898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
    Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
    Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis.
    Zhu X; Leav I; Leung YK; Wu M; Liu Q; Gao Y; McNeal JE; Ho SM
    Am J Pathol; 2004 Jun; 164(6):2003-12. PubMed ID: 15161636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.